“We have been using the Advanced Partial RhD typing kit since it first came
on the market and use it in preference to the panels we had in use prior to this.
We consider it essential that partial D phenotypes can be distinguished from the
classic weak D phenotypes in order for clinical judgments to be made, and the Advanced
Partial RhD typing kit performs this function well.”
Joyce Poole FRCPath CSci FIBMS
Reference Manager.
International Blood Group Reference Laboratory, Bristol, UK
Quotient signs Med Alliance Group as Distributor in Midwest.
read more >>>
Quotient Receives FDA Approval.
read more >>>
Bill Brady and Michael Hannan Added to Senior Management Team.
read more >>>
Quotient Bioscience Group Forms New Biodiagnostics Division.
read more >>>